BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37880458)

  • 1. DAB2IP stabilizes p27
    Zhou J; Deng Z; Pei X; Lai J; Qu W
    Funct Integr Genomics; 2023 Oct; 23(4):326. PubMed ID: 37880458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
    Li DY; Lin FF; Li GP; Zeng FC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.
    Ni QF; Zhang Y; Yu JW; Hua RH; Wang QH; Zhu JW
    Cell Prolif; 2020 Jan; 53(1):e12630. PubMed ID: 31713929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
    Lin H; Zeng W; Lei Y; Chen D; Nie Z
    Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
    Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
    Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.
    Xie D; Gore C; Zhou J; Pong RC; Zhang H; Yu L; Vessella RL; Min W; Hsieh JT
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19878-83. PubMed ID: 19903888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXA6 inhibits cell proliferation and induces apoptosis by suppressing the PI3K/Akt signaling pathway in clear cell renal cell carcinoma.
    Wu F; Wu S; Tong H; He W; Gou X
    Int J Oncol; 2019 Jun; 54(6):2095-2105. PubMed ID: 31081053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway.
    He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P
    Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.
    Yun EJ; Lin CJ; Dang A; Hernandez E; Guo J; Chen WM; Allison J; Kim N; Kapur P; Brugarolas J; Wu K; He D; Lai CH; Lin H; Saha D; Baek ST; Chen BPC; Hsieh JT
    Clin Cancer Res; 2019 Jul; 25(14):4542-4551. PubMed ID: 31000589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.
    Kim J; Jonasch E; Alexander A; Short JD; Cai S; Wen S; Tsavachidou D; Tamboli P; Czerniak BA; Do KA; Wu KJ; Marlow LA; Wood CG; Copland JA; Walker CL
    Clin Cancer Res; 2009 Jan; 15(1):81-90. PubMed ID: 19118035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma.
    Zeng L; Bai M; Mittal AK; El-Jouni W; Zhou J; Cohen DM; Zhou MI; Cohen HT
    Cancer Res; 2013 Sep; 73(17):5371-80. PubMed ID: 23824745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
    Zhu Q; Zhong AL; Hu H; Zhao JJ; Weng DS; Tang Y; Pan QZ; Zhou ZQ; Song MJ; Yang JY; He JY; Liu Y; Li M; Hu WM; Yang CP; Xiang T; Chen MY; Ma G; Guo L; Xia JC
    J Hematol Oncol; 2020 Jan; 13(1):2. PubMed ID: 31900208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
    Zhou J; Luo J; Wu K; Yun EJ; Kapur P; Pong RC; Du Y; Wang B; Authement C; Hernandez E; Yang J; Xiao G; Cha TL; Wu HC; Wu D; Margulis V; Lotan Y; Brugarolas J; He D; Hsieh JT
    Oncogene; 2016 Sep; 35(35):4663-74. PubMed ID: 26876207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway.
    Zhang Z; Zhang Y; Zhang R
    Med Oncol; 2023 Jan; 40(2):70. PubMed ID: 36588128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.